陇神戎发 (300534)

Gansu Longshenrongfa Pharmaceutical Industry CO. ,LTD

ASZ

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 30334.50
  • Circulating A-Shares(W): 30205.15
  • Earnings Per Share(RMB): 0.0891
  • Net Assets Per Share(RMB): 2.2748
  • Operating Revenue(W RMB): 64728.77
  • Total Profit(W RMB): 5322.77
  • Net Profit Attributable to Parent(W RMB): 2702.94
  • Net Profit Growth Rate(%): 9.13
  • Weighted Return on Equity(%): 3.9700
  • Operating Cash Flow Per Share(RMB): -0.2660
  • Undistributed Profit Per Share(RMB): 0.8457
  • Capital Reserve Per Share(RMB): 0.3203

2. Main Business

The main business covers:

  • Research and development of pharmaceutical products, medical products, and health care products.
  • Production and sales of Chinese patent medicines and health foods.
  • Production and sales of active pharmaceutical ingredients, a small amount of pharmaceutical intermediates, and chemical drugs.

3. Company Basic Information

  • Company Name: Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd.
  • Listing Date: 2016-09-13
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 10 Guofang Road, Dingyuan Town, Yuzhong County, Lanzhou City, Gansu Province
  • Website: www.lsrfzy.com
  • Company Profile: The company was established through the overall transformation of Gansu Longshenrongfa Pharmaceutical Co., Ltd. into a joint-stock company. With the approval of the Gansu Provincial State-owned Assets Supervision and Administration Commission, the company was restructured based on the audited net assets of 31.009 million yuan as of June 30, 2011, converted into 25 million shares. The company completed its industrial and commercial registration change at the Gansu Provincial Administration for Industry and Commerce on September 22, 2011.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Gansu Pharmaceutical Investment Group Co., Ltd. General Legal Person 9078.53 30.06
2 Gansu Xinglong Capital Management Co., Ltd. General Legal Person 2157.58 7.14
3 Gansu Provincial State-owned Assets Investment Group Co., Ltd. General Legal Person 135.10 0.45
4 ChinaAMC CSI Traditional Chinese Medicine ETF Fund 133.03 0.44

5. Concept Sectors

  • Food Safety
  • Infant and Child Concept
  • China-Russia Trade
  • Innovative Drugs
  • Specialized and Sophisticated Enterprises
  • Micro and Small Cap Stocks

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information